0 CHECKOUT

Autoinjectors to 2022

  • ID: 3064210
  • January 2015
  • Region: Global
  • Greystone Associates
Devices, Markets, Players, Strategies and Forecasts

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors – devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.

Highlights

- Analyzes therapeutic demand drivers and evaluates commercial autoinjector products in eleven major therapeutic segments

- Analyzes design factors, material selection issues, technologies and market development issues

- Profiles autoinjector device market participants, their product development activities, business strategies, and corporate alliances and affiliations

- Provides market data and forecasts to 2022

Note: Product cover images may vary from those shown

1. Executive Summary

2. The Market Opportunity
- Delivery Market Dynamics
- The Economics of Injectable Drugs
- What’s Driving the Growth in Autoinjectors?
- Prefilled Syringes Proliferating
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors

3. Autoinjectors: Commercial Devices
- Manual Injection Autoinjectors
- Automated Injection Autoinjectors
- Reusable Autoinjectors
- Disposable Autoinjectors
- Variable Dose Autoinjectors
- Product Specific Autoinjectors

4. Autoinjector Device Design Factors
- Material Selection Issues
- Part Counts and Device Cost
- Safety Features
- Needle Shielding
- Needle Insertion Depth
- Failsafe Activation
- Dose Inspection/Injection Confirmation
- Lyophilized Drugs/Reconstitution
- Human Engineering/Ergonomics

5. Autoinjector Drug Delivery: Key Therapeutic Sector Analysis
- Anticoagulants
- Autoimmune Diseases
- Rheumatoid Arthritis
- Multiple Sclerosis
- Psoriasis
- Emergency Medicine
- Epipen
- Hepatitis
- Hematopoietics
- Hormones
- Reproductive Health

6. Market Factors
- Regulatory Issues
- Device Branding
- Patient Compliance and Ease of Use
- Healthcare Economics

7. Company Profiles

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Bayer AG
  • LEO Laboratories Ltd.
  • Grünenthal GmbH
  • Medtronic, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pall Corporation